Urispas
$ 48,00 – $ 385,00Price range: $ 48,00 through $ 385,00
V gel
$ 55,00 – $ 225,00Price range: $ 55,00 through $ 225,00
Uroxatral
$ 52,00 – $ 324,00Price range: $ 52,00 through $ 324,00
Uroxatral is an effective medication specifically designed to manage the signs and symptoms of benign prostatic hyperplasia (BPH) in men. As an alpha-blocker, it works by relaxing the muscles in the prostate and the bladder neck to facilitate easier urination. This targeted action helps to significantly improve urine flow and reduces the feeling of incomplete bladder emptying. Patients commonly use this treatment to find relief from frequent nighttime urination and a weak urinary stream associated with an enlarged prostate. By focusing on localized muscle relaxation, Uroxatral provides a reliable way to enhance daily comfort and overall urinary health.
Active substance: Alfuzosin
SKU:
Uroxatral
Categories: Men's Health, Urinary Tract
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Uroxatral – Patient Information Guide
Uroxatral belongs to a class of medications known as alpha-1 adrenergic receptor antagonists. It is an FDA-approved prescription drug specifically indicated for the management of signs and symptoms associated with benign prostatic hyperplasia in adult men. By targeting selective adrenergic receptors in the lower urinary tract, it helps relieve urinary obstruction.
This oral formulation contains alfuzosin hydrochloride in an extended-release matrix designed for once-daily dosing. Proper medical evaluation is required prior to initiating therapy to ensure appropriate patient selection and safe administration.
| Attribute | Details |
|---|---|
| Active ingredient (INN) | Alfuzosin hydrochloride |
| Therapeutic class | Alpha-1 adrenergic antagonist |
| Dosage form | Extended-release tablet (10 mg) |
| Route of administration | Oral |
| Primary purpose | Benign prostatic hyperplasia (BPH) symptom relief |
| Prescription status | Prescription (Rx) only |
Indications and Pharmacologic Profile
Main uses
Uroxatral is FDA-approved for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in adult men. BPH is a non-cancerous enlargement of the prostate gland that can cause urinary frequency, urgency, weak urinary stream, hesitation, and nocturia. Uroxatral helps reduce these obstructive and irritative symptoms. It is not indicated for the treatment of hypertension, nor is it approved for use in female patients or pediatric populations. Off-label indications, such as management of acute urinary retention related to BPH prior to catheter removal, must be determined strictly by a qualified prescriber.
How the drug works
The mechanism of action relies on the selective inhibition of post-synaptic alpha-1 adrenoreceptors located in the prostate stroma, prostatic capsule, bladder neck, and proximal urethra. Blockade of these receptors leads to smooth muscle relaxation in the prostate gland and bladder neck. This structural relaxation decreases resistance to urine outflow, resulting in improved peak urinary flow rates and a reduction in bladder outlet obstruction. The drug acts locally on lower urinary tract tissue without impairing the contractility of the detrusor muscle.
What happens in the body
Uroxatral is formulated as an extended-release oral tablet. Under fed conditions, its absolute bioavailability is approximately 49%. Administering the tablet immediately following a meal substantially enhances systemic absorption compared to fasting administration. Peak plasma concentrations are achieved approximately 8 hours after dosing. Alfuzosin undergoes extensive hepatic metabolism, primarily via the cytochrome P450 3A4 (CYP3A4) enzyme pathway, yielding inactive metabolites. The mean terminal elimination half-life is approximately 10 hours. Elimination occurs primarily through feces (69%) and urine (24%).
Dosing and Administration Guidelines
How to take it
The standard recommended dosage for adult male patients is 10 mg taken orally once daily. The tablet must be ingested immediately following the same meal every day to ensure consistent bioavailability. Patients must swallow the tablet whole with water. Tablets should never be crushed, chewed, split, or dissolved, as breaking the extended-release membrane alters the pharmacokinetic delivery, leading to rapid drug absorption and an increased risk of severe adverse effects. Dose adjustments are not required for mild renal impairment, though caution is warranted in moderate renal impairment.
If you skip a dose
If a daily dose is forgotten, it should be taken immediately after the next meal on the same day if remembered. If the patient does not realize the omission until near the time of the next scheduled dose, the missed dose should be skipped entirely, and the routine administration schedule resumed. Patients must never double up on tablets or take extra doses to compensate for a missed dose, as excessive systemic exposure elevates the risk of marked orthostatic hypotension and syncope.
Safety Profile and Drug Interactions
Compatibility with other medicines
Concomitant administration of Uroxatral with potent CYP3A4 inhibitors–such as ketoconazole, itraconazole, or ritonavir–is strictly contraindicated due to significant increases in alfuzosin exposure and plasma concentration. Moderate CYP3A4 inhibitors (e.g., diltiazem, erythromycin) should be used with caution. Co-administration with other alpha-1 receptor blockers is contraindicated because of additive hypotensive effects. Concomitant use with blood-pressure-lowering agents or phosphodiesterase-5 (PDE5) inhibitors (such as sildenafil, tadalafil, or vardenafil) can cause additive vasodilation; caution and appropriate monitoring are advised.
Adverse reactions
Clinical trials indicate that the most common adverse events associated with alfuzosin include dizziness (reported in approximately 6% of patients), upper respiratory tract infection, headache, and fatigue. Abdominal pain, nausea, and constipation may also occur. Alfuzosin exhibits a lower incidence of ejaculatory dysfunction compared to certain other alpha-1 adrenergic antagonists. Most reported adverse reactions are mild to moderate. Persistent or severe side effects should be evaluated by a healthcare professional.
Food and alcohol interactions
Taking Uroxatral immediately after a meal is clinically essential. Fasting significantly reduces peak blood concentration and overall drug absorption, which may compromise therapeutic efficacy. Alcohol consumption should be limited or avoided while taking this medication. Alcohol exerts vasodilatory effects that can potentiate the orthostatic hypotensive properties of alfuzosin, increasing the risk of dizziness, lightheadedness, and fainting episodes.
Precautions and Red Flags
Important precautions
Uroxatral can cause orthostatic hypotension and syncope, particularly within the initial days of treatment or following dose adjustments. Patients should exercise caution when driving or operating machinery until individual response to the medication is established. Severe hepatic impairment (Child-Pugh Class B and C) is a contraindication due to significantly decreased drug clearance. Patients scheduled for cataract surgery must inform their ophthalmologist of current or prior alpha-blocker therapy due to the risk of Intraoperative Floppy Iris Syndrome (IFIS).
Red flags
Immediate medical attention is required if patients experience signs of a severe hypersensitivity reaction, including swelling of the face, lips, tongue, or throat, or difficulty breathing. Emergency care must be sought for prolonged or painful erections lasting more than four hours (priapism), as immediate intervention is necessary to prevent permanent tissue damage. Severe dizziness, loss of consciousness, chest pain, or irregular heart rhythms require immediate emergency evaluation at a healthcare facility, such as a medical center in Houston or local emergency services.
Storage and expiration
Store Uroxatral tablets at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C). Protect the medication from excess moisture, heat, and direct light. Keep the tablets in their original child-resistant container and store them safely out of reach of children and domestic animals. Do not use this medication past the expiration date printed on the packaging.
Frequently Asked Questions
How long does it take for Uroxatral to show noticeable improvement in urinary flow?
Initial symptomatic relief may be observed within a few days of initiating therapy. However, achieving the full therapeutic benefit regarding urinary flow rate and symptom reduction typically requires consistent daily administration over several weeks, as evaluated by your healthcare provider.
Can Uroxatral cause sudden drops in blood pressure when standing up?
Yes, orthostatic hypotension can occur, especially during the first few days of starting the medication. Patients are advised to stand up slowly from sitting or lying positions to reduce the risk of postural dizziness, lightheadedness, or syncopal episodes.
What should I do if I am scheduled for cataract surgery while taking Uroxatral?
You must inform your ophthalmic surgeon prior to the procedure that you are taking or have previously taken an alpha-1 blocker. This allows the surgical team to prepare for Intraoperative Floppy Iris Syndrome (IFIS) and utilize specialized techniques during the cataract extraction.
Why must Uroxatral be taken specifically right after a meal?
Taking Uroxatral immediately after food significantly enhances the absorption and bioavailability of the extended-release formulation. Administering the drug on an empty stomach lowers systemic concentration and reduces its clinical effectiveness.
Is Uroxatral prescribed to treat high blood pressure?
No. Although alfuzosin acts by relaxing smooth muscle in blood vessels to some degree, Uroxatral is FDA-approved exclusively for managing benign prostatic hyperplasia (BPH) symptoms and is not indicated as a primary antihypertensive agent.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA requirements.
Additional information
| Dosage |
10mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Bottled Viagra
$ 114,00 – $ 324,00Price range: $ 114,00 through $ 324,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cardura
$ 40,00 – $ 313,00Price range: $ 40,00 through $ 313,00
Active substance: Doxazosin
More Details
This product has multiple variants. The options may be chosen on the product page
Doxazosin
$ 42,00 – $ 332,00Price range: $ 42,00 through $ 332,00
Active substance: Doxazosin
More Details
This product has multiple variants. The options may be chosen on the product page
Ferrous
$ 60,00 – $ 487,00Price range: $ 60,00 through $ 487,00
Active substance: Ferrous sulfate
More Details
This product has multiple variants. The options may be chosen on the product page
Fildena Strong
$ 49,00 – $ 213,00Price range: $ 49,00 through $ 213,00
Active substance: Sildenafil Citrate
More Details
This product has multiple variants. The options may be chosen on the product page
Fildena XXX
$ 48,00 – $ 137,00Price range: $ 48,00 through $ 137,00
Active substance: Sildenafil Citrate
More Details
This product has multiple variants. The options may be chosen on the product page
Flomax
$ 55,00 – $ 335,00Price range: $ 55,00 through $ 335,00
Active substance: Tamsulosin
More Details
This product has multiple variants. The options may be chosen on the product page
Lotrisone
$ 41,00 – $ 254,00Price range: $ 41,00 through $ 254,00
Active substance: betamethasone, Clotrimazole
More Details
This product has multiple variants. The options may be chosen on the product page
